Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019

SELL
$10.88 - $17.6 $329,217 - $532,558
-30,259 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$15.51 - $17.61 $528,891 - $600,501
-34,100 Reduced 52.98%
30,259 $533,000
Q4 2018

Feb 14, 2019

SELL
$14.52 - $19.72 $92,260 - $125,300
-6,354 Reduced 8.99%
64,359 $1.12 Million
Q3 2018

Nov 14, 2018

SELL
$14.85 - $16.35 $270,953 - $298,322
-18,246 Reduced 20.51%
70,713 $1.05 Million
Q2 2018

Aug 14, 2018

BUY
$13.8 - $16.8 $333,394 - $405,871
24,159 Added 37.28%
88,959 $1.41 Million
Q1 2018

May 15, 2018

BUY
$13.8 - $16.2 $894,240 - $1.05 Million
64,800 New
64,800 $920,000

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.